awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q48260043-C4D86B30-023C-436E-8AF5-27CC4809E98C
Q48260043-C4D86B30-023C-436E-8AF5-27CC4809E98C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q48260043-C4D86B30-023C-436E-8AF5-27CC4809E98C
Randomised natalizumab discontinuation study: taper protocol may prevent disease reactivation.
P2860
Q48260043-C4D86B30-023C-436E-8AF5-27CC4809E98C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q48260043-C4D86B30-023C-436E-8AF5-27CC4809E98C
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
53d0cdfe2ddaedd04c7b300f49d1856ba8a59230
P2860
Natalizumab discontinuation in patients with multiple sclerosis: Profiling risk and benefits at therapeutic crossroads.